151 results
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
29 Mar 24
TherapeuticsMD Announces Full Year 2023 Financial Results
4:29pm
innovative products to support the lifespan of women from pregnancy prevention through menopause. In December 2022, the Company changed its business
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
and commercializing innovative products to support the lifespan of women from pregnancy prevention through menopause. In December 2022, the Company changed its
8-K
EX-99.1
w7worl6
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
8-K
EX-99.1
bemgy5
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
fcs4u3tkw
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.1
v4ttr9l5 axbfis
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm
8-K
EX-99.1
6xhc5gh
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-99.1
0kr66i6np grh
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
3rifw7
12 Sep 22
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
7:01am
8-K
EX-99.1
7htfhyjx7z kysqg
15 Aug 22
TherapeuticsMD Announces Second Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
ftsrc1
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
SC 14D9/A
EX-99
ma9km6b94
13 Jul 22
Tender offer solicitation (amended)
7:53am
SC 14D9
3c9cb7z
10 Jun 22
Tender offer solicitation
6:51pm